Due to their ease of use and the abundance of data gathered from them, wearable devices are expected to become broadly incorporated into clinical trial design. However, the magnitude of data obtained by these devices requires analysis by a skilled biostatistician in order to draw significant and useful conclusions. A webinar by Cytel discusses how to bridge this gap.
“The good news for biostatisticians is that wearables like the accelerometer, produce an array of data,– far more data than has ever been available before,– and this allows the potential for a more meaningful quantification compared to what has been previously possible. The quantitative processes for converting raw data to meaningful insights requires collaborating with a new statistical skill set for many sponsors.” Watch the webinar here.
(Source: Cytel, 3/12/21)